Ciclesonide

Ciclesonide, 126544-47-6, Alvesco, Omnaris, Zetonna, RPR251526, RPR-251526, Ciclesonida, DTXSID9046659, Alvesco 80, Alvesco 160, (R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate, BI54903, DTXCID7026659, S59502J185, ciclesonidum, Aservo EquiHaler, RefChem:57392, R01AD13, R03BA08, 2-((1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo(10.8.0.02,?.0?,?.013,1?)icosa-14,17-dien-8-yl)-2-oxoethyl 2-methylpropanoate, Ciclesonide (Standard), Ciclesonide [INN], [2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate, 141845-82-1, [2-[(1S,2S,4R,8S,9S,11S,12S,13R)-6-Cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate, 2-{6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl}-2-oxoethyl 2-methylpropanoate, Osonase, Osonide, Omnair, RPR 251526, Alvesco HFA, Omnaris HFA, 2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl isobutyrate, Alvesco (TN), Omnaris (TN), Ciclesonide [USAN:INN], sobutyrate, BTR-15K, Ciclesonide (JAN/USAN/INN), BTR-15, TBN-15, Ciclesonide CRS, LUKZNWIVRBCLON-GXOBDPJESA-N, UNII-S59502J185, NCGC00167484-01, Zetonna (TN), Alvesco, Ciclesonide, BYK-20426, BY-9010, KS-1165, CICLESONIDE [MI], CICLESONIDE [JAN], CICLESONIDE [USAN], CICLESONIDE [VANDF], SCHEMBL3688, CICLESONIDE [MART.], CICLESONIDE [WHO-DD], B-9207-015, GTPL7469, orb1305357, orb3025781, el-87-6, CHEMBL2040682, CHEBI:31397, Ciclesonide, >=98% (HPLC), HY-B0625R, CICLESONIDE [ORANGE BOOK], WLZ3795, CICLESONIDE [EP MONOGRAPH], HMS3714N07, EX-A4195, HY-B0625, Tox21_112486, BDBM50247997, EBC-27297, MSK011037, s4646, Ciclesonide containing impurity A CRS, AKOS015994702, AC-1330, CCG-269962, DB01410, FC20428, MSK011037-1000A, NCGC00167972-01, Pregna-1,4-diene-3,20-dione, 16,17-(((R)-cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha)-, Pregna-1,4-diene-3,20-dione, 16,17-((cyclohexylmethylene)bis(oxy))-11-hydroxy-21-(2-methyl-1-oxopropoxy)-, (11beta,16alpha(R))-, Ciclesonide 100 microg/mL in Acetonitrile, C3701, CAS-141845-82-1, CS-0694790, NS00006507, C72110, D01703, Ciclesonide Solution in Acetonitrile, 1000ug/mL, EN300-19766990, SR-01000942227, Q5119448, SR-01000942227-1, BRD-K35245662-001-01-2, Ciclesonide, European Pharmacopoeia (EP) Reference Standard, (11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4-diene-3,20-dione, (11beta,16alpha)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)pregna-1,4-diene-3,20-dione, [2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxo-ethyl] 2-methylpropanoate, 2-((6aR,6bS,7S,8aS,8bS,10R,11aR,12aS,12bS)-10-cyclohexyl-7-hydroxy-6a,8a-dimethyl-4-oxo-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl i, 2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl 2-methylpropanoate, 2-[(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-8-cyclohexyl-5-hydroxy-4a,6a-dimethyl-2-oxo-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-phenanthro[1',2':1,2]cyclopenta[3,4-d][1,3]dioxol-6b-yl]-2-oxoethyl 2-methylpropanoate, 2H-Naphth (2',1':4,5) indeno (1,2-d) (1,3) dioxole, pregna-1,4-diene-3,20-dione deriv., PREGNA-1,4-DIENE-3,20-DIONE, 16,17-(((R)-CYCLOHEXYLMETHYLENE)BIS(OXY))-11-HYDROXY-21-(2-METHYL-1-OXOPROPOXY)-, (11.BETA.,16.ALPHA.)